Opponents of California’s Abortion Rights Measure Mislead on Expense to Taxpayers
California Together, a campaign led by religious and anti-abortion groups, is hoping to persuade voters to reject a ballot measure ...
Medicaid Enrollment Soared by 25% During the COVID-19 Pandemic
Medicaid, the government-funded U.S. health insurer for people with low incomes, grew by about 25% between February 2020 and May ...
Doctors Rush to Use Supreme Court Ruling to Escape Opioid Charges
The Supreme Court’s unanimous ruling complicates the Department of Justice’s ongoing efforts to hold irresponsible prescribers criminally liable for fueling ...
Perceptions Over Data
We study patient perceptions on the socioeconomic consequences of the opioid epidemic.
Summer of Abortion
Summer has come and gone, and one thing is clear: it was the summer of abortion.
Rise of the Polypill
Renewed calls for polypills come after studies showed its value in preventive medicine.
Humans Evolved with their Microbiomes
When the first humans moved out of Africa, they carried their gut microbes with them. Turns out, these microbes also ...
Did the US Jump the Gun With the New Omicron-Targeted Vaccines?
For those familiar with the business tactics of the pharmaceutical industry, that exuberant messaging has caused considerable heartburn and raised ...
Medicine Needs Civil Disobedience
Controlled, willful acts of resistance have been a powerful agent of change throughout history. We need it in medicine, now ...
Emerson Fought the Materialists
Ralph Waldo Emerson defined the humanist origins of medicine. We praise his work, but we forget he fought against the ...
Can Medicine Return to its Roots?
We built modern medicine on data. They provide certainty when facing the unknown. But the heart of medicine is uncertainty. ...
Stop Calling Medicine a Right
We should question why we look at medicine as a right. It is a legal concept that cannot address uncertainty ...
Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence
Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read more